 |
|
Update on association between exposure to renin-angiotensin-aldosterone system inhibitors and coronavirus disease 2019 in South Korea
Jeongkuk Seo, Minkook Son
Korean J Intern Med. 2021;36(Suppl 1):S114-S122. Published online 2021 Feb 25 DOI: https://doi.org/10.3904/kjim.2020.380
|
|
Citations to this article as recorded by
 Individual risk factors associated with SARS-CoV-2 infection during Alpha variant in high-income countries: a systematic review and meta-analysis
Marta Moniz, Sofia Pereira, Patricia Soares, Pedro Aguiar, Helena Donato, Andreia Leite
Frontiers in Public Health.2024;[Epub] CrossRef Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in East-Asian patients with COVID-19
Nancy Xurui Huang, Qi Yuan, Fang Fang, Bryan P. Yan, John E. Sanderson, Masaki Mogi
PLOS ONE.2023; 18(1): e0280280. CrossRef COVID-19 and arrhythmia: An overview
Joseph A Varney, Vinh S Dong, Tiffany Tsao, Mariam S Sabir, Amanda T Rivera, Suhaib Ghula, Kevin Emmanuel Moriles, Mohana Laasya Cherukuri, Rahim Fazal, Chelsea B Azevedo, Rana MK Mohamed, Garrett R Jackson, Shannon E Fleming, Diana E Rochez, Kirellos S A
Journal of Cardiology.2022; 79(4): 468. CrossRef Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis
Abraham Degarege, Zaeema Naveed, Josiane Kabayundo, David Brett-Major
Pathogens.2022; 11(5): 563. CrossRef Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
Jordan Loader, Frances C. Taylor, Erik Lampa, Johan Sundström
Journal of the American Heart Association.2022;[Epub] CrossRef The effects of hypertension on the prognosis of coronavirus disease 2019: a systematic review and meta-analysis on the interactions with age and antihypertensive treatment
Alimamy Umaru Kabia, Ping Li, Zhichao Jin, Xiaojie Tan, Yilong Liu, Yuqi Feng, Keyao Yu, Ming Hu, Dongming Jiang, Guangwen Cao
Journal of Hypertension.2022; 40(12): 2323. CrossRef Comparison of infection risks and clinical outcomes in patients with and without SARS‐CoV‐2 lung infection under renin–angiotensin–aldosterone system blockade: Systematic review and meta‐analysis
Chang Chu, Shufei Zeng, Ahmed A. Hasan, Carl‐Friedrich Hocher, Bernhard K. Krämer, Berthold Hocher
British Journal of Clinical Pharmacology.2021; 87(6): 2475. CrossRef Update Alert 7: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults
Katherine Mackey, Devan Kansagara, Kathryn Vela
Annals of Internal Medicine.2021; 174(2): W25. CrossRef Renin‐Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID‐19
Jordan Loader, Erik Lampa, Stefan Gustafsson, Thomas Cars, Johan Sundström
Journal of the American Heart Association.2021;[Epub] CrossRef Update Alert 5: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults
Katherine Mackey, Devan Kansagara, Kathryn Vela
Annals of Internal Medicine.2020; 173(12): 167. CrossRef
|